FBRX – Forte Biosciences Inc
Forte Biosciences, Inc.FBRX
$27.27Name : Forte Biosciences, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $341,609,536.00
EPSttm : -0.08
Forte Biosciences, Inc.
$27.27
3.81%$1.00Float Short %
1.3
Margin Of Safety %
Put/Call OI Ratio
0.72
EPS Next Q Diff
0.24
EPS Last/This Y
7.85
EPS This/Next Y
0.84
Price
27.61
Target Price
63.75
Analyst Recom
1
Performance Q
87.81
Relative Volume
1.02
Beta
3.25
Ticker: FBRX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-12-02 | FBRX | 19.03 | 1.88 | 0.00 | 222 |
| 2025-12-03 | FBRX | 18.43 | 1.88 | 0.00 | 222 |
| 2025-12-04 | FBRX | 20.55 | 1.88 | 0.00 | 222 |
| 2025-12-05 | FBRX | 20.29 | 1.88 | 0.00 | 222 |
| 2025-12-08 | FBRX | 19.65 | 1.88 | 0.00 | 222 |
| 2025-12-09 | FBRX | 19.93 | 1.86 | 999.99 | 223 |
| 2025-12-10 | FBRX | 20.21 | 1.86 | 999.99 | 223 |
| 2025-12-11 | FBRX | 22.68 | 1.86 | 999.99 | 223 |
| 2025-12-12 | FBRX | 21.34 | 1.99 | 0.00 | 233 |
| 2025-12-15 | FBRX | 21.83 | 1.76 | 1.00 | 243 |
| 2025-12-16 | FBRX | 23.19 | 1.21 | 0.00 | 691 |
| 2025-12-17 | FBRX | 24.63 | 1.21 | 0.00 | 692 |
| 2025-12-18 | FBRX | 28.45 | 1.17 | 0.00 | 702 |
| 2025-12-19 | FBRX | 29.64 | 1.20 | 0.00 | 696 |
| 2025-12-22 | FBRX | 29.38 | 0.76 | 0.00 | 524 |
| 2025-12-23 | FBRX | 26.61 | 0.74 | 0.00 | 534 |
| 2025-12-26 | FBRX | 27.78 | 0.72 | 0.00 | 542 |
| 2025-12-29 | FBRX | 26.03 | 0.72 | 0.00 | 542 |
| 2025-12-30 | FBRX | 26.26 | 0.72 | 0.00 | 542 |
| 2025-12-31 | FBRX | 27.65 | 0.72 | 0.00 | 542 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-12-02 | FBRX | 19.09 | - | - | -4.32 |
| 2025-12-03 | FBRX | 18.31 | - | - | -4.32 |
| 2025-12-04 | FBRX | 20.49 | - | - | -4.32 |
| 2025-12-05 | FBRX | 19.93 | - | - | -4.32 |
| 2025-12-08 | FBRX | 19.74 | - | - | -4.32 |
| 2025-12-09 | FBRX | 20.09 | - | - | -4.32 |
| 2025-12-10 | FBRX | 20.30 | - | - | -4.32 |
| 2025-12-11 | FBRX | 22.79 | - | - | -4.32 |
| 2025-12-12 | FBRX | 21.58 | - | - | -4.32 |
| 2025-12-15 | FBRX | 21.96 | - | - | -4.32 |
| 2025-12-16 | FBRX | 21.96 | - | - | -4.32 |
| 2025-12-17 | FBRX | 24.65 | - | - | -4.32 |
| 2025-12-18 | FBRX | 28.58 | - | - | -4.32 |
| 2025-12-19 | FBRX | 29.56 | - | - | -4.32 |
| 2025-12-22 | FBRX | 29.10 | - | - | -4.32 |
| 2025-12-23 | FBRX | 27.10 | - | - | -4.32 |
| 2025-12-26 | FBRX | 27.72 | - | - | -4.32 |
| 2025-12-29 | FBRX | 26.07 | - | - | -4.32 |
| 2025-12-30 | FBRX | 25.93 | - | - | -4.32 |
| 2025-12-31 | FBRX | 27.61 | - | - | -4.32 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-12-02 | FBRX | 0.00 | 2.39 | 4.00 |
| 2025-12-03 | FBRX | 0.00 | 2.39 | 4.00 |
| 2025-12-04 | FBRX | 0.00 | 2.39 | 4.00 |
| 2025-12-05 | FBRX | 0.00 | 2.39 | 4.00 |
| 2025-12-08 | FBRX | 0.00 | 2.40 | 4.00 |
| 2025-12-09 | FBRX | 0.00 | 2.40 | 4.00 |
| 2025-12-10 | FBRX | 0.00 | 2.40 | 1.21 |
| 2025-12-11 | FBRX | 0.00 | 2.40 | 1.21 |
| 2025-12-12 | FBRX | 0.00 | 2.40 | 1.21 |
| 2025-12-15 | FBRX | 0.00 | 2.40 | 1.21 |
| 2025-12-16 | FBRX | 0.00 | 2.40 | 1.21 |
| 2025-12-17 | FBRX | 0.00 | 2.40 | 1.21 |
| 2025-12-18 | FBRX | 0.00 | 2.40 | 1.21 |
| 2025-12-19 | FBRX | 0.00 | 2.40 | 1.21 |
| 2025-12-22 | FBRX | 0.00 | 2.37 | 1.21 |
| 2025-12-23 | FBRX | 0.00 | 2.37 | 1.21 |
| 2025-12-26 | FBRX | 0.00 | 2.37 | 1.30 |
| 2025-12-29 | FBRX | 0.00 | 10.57 | 1.30 |
| 2025-12-30 | FBRX | 0.00 | 10.57 | 1.30 |
| 2025-12-31 | FBRX | 0.00 | 10.57 | 1.30 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.99
Avg. EPS Est. Current Quarter
-1.18
Avg. EPS Est. Next Quarter
-0.74
Insider Transactions
Institutional Transactions
10.57
Beta
3.25
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
8
Growth Score
19
Sentiment Score
38
Actual DrawDown %
97.5
Max Drawdown 5-Year %
-99.6
Target Price
63.75
P/E
Forward P/E
PEG
P/S
P/B
4.06
P/Free Cash Flow
EPS
-4.44
Average EPS Est. Cur. Y
-4.32
EPS Next Y. (Est.)
-3.48
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
1.02
Return on Equity vs Sector %
-88.8
Return on Equity vs Industry %
-73.5
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.12
EBIT Estimation
Forte Biosciences, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 16
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
stock quote shares FBRX – Forte Biosciences Inc Stock Price stock today
news today FBRX – Forte Biosciences Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch FBRX – Forte Biosciences Inc yahoo finance google finance
stock history FBRX – Forte Biosciences Inc invest stock market
stock prices FBRX premarket after hours
ticker FBRX fair value insiders trading